Table:
begin	end	state
1	19	cytoplasmic
20	42	transmembrane
43	47	non-cytoplasmic
48	68	transmembrane
69	78	cytoplasmic
79	104	transmembrane
105	130	non-cytoplasmic
131	153	transmembrane
154	159	cytoplasmic
160	181	transmembrane
182	212	non-cytoplasmic
213	234	transmembrane
235	243	cytoplasmic
244	263	transmembrane
264	268	cytoplasmic
269	292	transmembrane
293	310	non-cytoplasmic
311	334	transmembrane
335	636	cytoplasmic

Input:
>BWI76_RS27160
MSSDIKIKVQSFGRFLSNMVMPNIGAFIAWGIITALFIPTGWLPNETLAKLVGPMITYLL
PLLIGYTGGKLVGGERGGVVGAITTMGVIVGADMPMFLGSMIAGPLGGWAIKKFDVWVDG
KIKSGFEMLVNNFSAGIIGMILAILAFLGIGPAVEILSKILAAGVNFMVAHEMLPLASIF
VEPAKILFLNNAINHGIFSPLGIQQSHELGKSIFFLIEANPGPGMGVLLAYMFFGRGSAK
QSAGGAAIIHFLGGIHEIYFPYVLMNPRLILAVILGGMTGVFTLTILNGGLVSPASPGSI
LAVLAMTPKGAYFANIAAIVAAMAVSFVVAAVLLKTSKVKEEDDIEAATRRMHDMKAESK
GGATPLAAGDVANDLSHVRKIIVACDAGMGSSAMGAGVLRKKVQDAGLSNISVTNCAINN
LPPDVDLVITHRDLTERAMRQVPQAQHISLTNFLDSGLYTSLTERLVAAQRHTDNEEKVR
DSLKDSFDAADTNLFKLGAENIFLGRKAATKEEAILFAGEQLVKGGYVEPEYVQAMLDRE
KLTSTYLGESIAVPHGTIEAKDRVLKTGIVFCQYPEGVRFGEEEDEVARLVIGIAARNNE
HIQVITSLTNALDDESVIERLTKTTSVDEVLTLLKG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server